1-9 of 9
Anthony Sferruzza, PhD
Close
Sort by
Journal Articles

Three Novel Alternative Splicing Mutations in BCR-ABL1 detected in CML Patients with Resistance to Kinase Inhibitors.

Wanlong Ma, Hagop Kantarjian, Jorge Cortes, MD, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Maher Albitar, M.D.
Journal: Blood
Blood (2009) 114 (22): 1107.
https://doi.org/10.1182/blood.V114.22.1107.1107
Published: 2009
Journal Articles

Clinical Relevance of Circulating Poly-Ubiquitin as a Prognostic Indicator in Chronic Lymphocytic Leukemia.

Wanlong Ma, Hagop M. Kantarjian, MD, Xiuqiang Wang, Susan O'Brien, Chen-Hsiung Yeh, XI Zhang, Zeev Estrov, MD, Anthony Sferruzza, PhD, William Weirda, Michael Keating, MD, Maher Albitar, MD
Journal: Blood
Blood (2009) 114 (22): 1240.
https://doi.org/10.1182/blood.V114.22.1240.1240
Published: 2009
Journal Articles

Use of Ubiquitin-Proteasome System Profiling for Differentiating Between Various Leukemic Processes.

Ke Zhang, Hagop M. Kantarjian, MD, Wanlong Ma, XI Zhang, Xiuqiang Wang, Zeev Estrov, MD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Michael Keating, MD, Maher Albitar, M.D.
Journal: Blood
Blood (2009) 114 (22): 4712.
https://doi.org/10.1182/blood.V114.22.4712.4712
Published: 2009
Journal Articles

Mutation and Single-Nucleotide Polymorphism (rs16754) in Wilms Tumor-1 Gene Are Independent Prognostic Factors in Acute Myeloid Leukemia.

Wanlong Ma, Hagop Kantarjian, MD, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Maher Albitar, M.D.
Journal: Blood
Blood (2009) 114 (22): 995.
https://doi.org/10.1182/blood.V114.22.995.995
Published: 2009
Journal Articles

Significant Association Between Promoter Polymorphism of the Erythropoietin Gene and Myelodysplastic Syndrome.

Wanlong Ma, Hagop Kantarjian, MD, Ke Zhang, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Elihu Estey, MD, Maher Albitar, M.D.
Journal: Blood
Blood (2009) 114 (22): 3825.
https://doi.org/10.1182/blood.V114.22.3825.3825
Published: 2009
Journal Articles

Clinical Significance of Circulating Ki-67 Protein and Caspase-3 Activity Levels in Chronic Myeloid Leukemia.

Jean-Marie Bruey, Hagop M. Kantarjian, MD, Zeev Estrov, MD, Wanlong Ma, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Maher Albitar, M.D.
Journal: Blood
Blood (2009) 114 (22): 4249.
https://doi.org/10.1182/blood.V114.22.4249.4249
Published: 2009
Journal Articles

MPL Mutation Profile in JAK2 Mutation-Negative Patients with Myeloproliferative Neoplasms.

Wanlong Ma, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Jennifer Uyeji, Maher Albitar, M.D.
Journal: Blood
Blood (2009) 114 (22): 1891.
https://doi.org/10.1182/blood.V114.22.1891.1891
Published: 2009
Journal Articles

Splice Variant JAK2 Transcript Deleting Exon 14 in Patients with Chronic Myeloproliferative Neoplasms.

Wanlong Ma, Hagop Kantarjian, MD, XI Zhang, Xiuqiang Wang, Zhong Zhang, MD, PhD, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Susan O'Brien, Maher Albitar, M.D.
Journal: Blood
Blood (2009) 114 (22): 2161.
https://doi.org/10.1182/blood.V114.22.2161.2161
Published: 2009
Journal Articles

Clinical Significance of Circulating Ki-67 Protein and Caspase-3 Activity Levels in Patients with Acute Myeloid Leukemia.

Jean-Marie Bruey, Hagop M. Kantarjian, MD, Zeev Estrov, MD, Wanlong Ma, Chen-Hsiung Yeh, Anthony Sferruzza, PhD, Elihu Estey, MD, Maher Albitar, M.D.
Journal: Blood
Blood (2009) 114 (22): 3104.
https://doi.org/10.1182/blood.V114.22.3104.3104
Published: 2009